however , significant reactivity to malignant prostate was also observed in 89 of 192 ( 46 % ) controls comprised of patients with other than carcinoma of the prostate [ including 91 patients with benign prostatic hypertrophy of which 46 ( 51 % ) possessed significant reactivity to malignant prostate ] and healthy adults .
C0600139
carcinoma of the prostate
C0033572
prostate